PDB ID or protein name

Undefined (117 proteins)

Family Protein Name PDB ID Species Num. Subunits Num. TM Sec. Structs. Hydrophobic Thickness or Depth (Å) Tilt Angle (°) ΔGtransfer (kcal/mol)
1.1.68.01. Transmembrane protein 141 2lor Homo sapiens 1 2 24.4 ± 4.0 21 ± 0 -22.2
1.2.17.03. Syntaxin-1 2xhe Monosiga brevicollis (Choanoflagellate) 2 0 4.1 ± 2.3 78 ± 3 -5.3
1.3.01.01. Transmembrane beta-barrel platform protein 2jmm Designed proteins 1 8 23.9 ± 1.3 4 ± 4 -32.3
2.1.24.01. Pore-forming peptide ameobapore A 1of9 Entamoeba histolytica 1 0 1.5 ± 1.0 13 ± 18 -2.3
2.1.46.01. Protein yciE 3ogh Escherichia coli 2 0 4.0 ± 1.0 88 ± 4 -9.7
2.1.48.01. Glycerol dehydrogenase 1kq3 Thermotoga maritima 1 0 2.5 ± 1.8 80 ± 5 -4.3
2.2.05.02. Mavicyanin 1ws8 Cucurbita pepo 1 0 3.7 ± 0.5 31 ± 8 -6.5
2.2.09.01. Kelch-like protein 7 3ii7 Homo sapiens 1 0 2.6 ± 1.8 90 ± 16 -6.5
2.2.09.02. Diisopropyl-fluorophosphatase 3o4p Loligo vulgaris (Common European squid) 1 0 4.6 ± 1.3 82 ± 5 -6.6
2.2.34.11. Kalata B1, all-D analogue 2jue Designed proteins 1 0 3.7 ± 1.0 82 ± 17 -5.5
2.2.34.11. Melanocortin agonist based on kalata-B1 2lur Designed proteins 1 0 6.5 ± 1.0 74 ± 21 -6.7
2.2.41.01. Chimeric beta-defensin 2/3 2lxo Designed proteins 1 0 3.6 ± 0.8 56 ± 14 -5.6
2.2.43.01. Hypothetical protein SpyM3_0169 1pg6 Streptococcus pyogenes 1 0 7.6 ± 1.5 57 ± 6 -7.2
2.2.48.01. Hypothetical molybdopterin biosynthesis MoeA protein 1uz5 Pyrococcus horikoshii 1 0 4.7 ± 1.7 79 ± 2 -5.0
2.2.55.01. Shewanella peptidase 3nji Shewanella oneidensis 2 0 4.0 ± 0.9 81 ± 7 -5.6
2.3.06.18. Protein lpg2422 4m0m Legionella pneumophila 1 0 4.6 ± 2.9 76 ± 6 -6.9
2.3.07.01. Endoglucanase 1vho Thermotoga maritima 1 0 5.4 ± 0.2 89 ± 1 -7.0
2.3.10.01. Glycosyltransferase GtfA 1pn3 Amycolatopsis orientalis (Nocardia orientalis) 1 0 7.2 ± 1.0 80 ± 5 -7.7
2.3.13.01. Glutathione transferase GST1-4 3g7j Anopheles dirus 2 0 3.1 ± 0.3 88 ± 1 -7.6
2.3.13.01. Stringent starvation protein A 3mdk Pseudomonas putida 2 0 4.8 ± 0.1 89 ± 0 -5.5
2.3.13.04. Glutathione peroxidase-like protein 2vup Trypanosoma brucei 1 0 3.0 ± 1.7 84 ± 7 -4.1
2.3.13.05. Putative peroxiredoxin Rv2238c/MT2298 1xvw Mycobacterium tuberculosis 1 0 4.6 ± 1.0 20 ± 5 -7.0
2.3.17.01. Phospho-2-dehydro-3-deoxyheptonate aldolase 1of8 Saccharomyces cerevisiae 2 0 7.2 ± 0.4 80 ± 6 -9.3
2.3.22.01. Uncharacterized protein 1rtt Pseudomonas aeruginosa 1 0 3.1 ± 2.5 70 ± 22 -4.1
2.3.22.02. NrdI protein 2x2o Bacillus cereus 1 0 3.6 ± 0.5 77 ± 4 -4.6
2.3.22.02. NrdI protein 2xod Bacillus anthracis 1 0 4.1 ± 0.4 72 ± 3 -4.8
2.3.24.01. Phosphonoacetaldehyde hydrolase 1rdf Bacillus cereus 1 0 4.3 ± 0.9 68 ± 4 -5.1
2.3.24.01. Phosphatase YidA 1rkq Escherichia coli 1 0 2.5 ± 1.3 79 ± 9 -4.1
2.3.24.02. Phosphoglycolate phosphatase 1l6r Thermoplasma acidophilum 1 0 3.6 ± 0.5 86 ± 3 -7.5
2.3.24.02. Hydrolase 3n1u Legionella pneumophila 4 0 5.6 ± 0.6 90 ± 1 -10.8
2.3.24.02. Predicted hydrolase 3mpo Lactobacillus brevis 1 0 3.6 ± 0.0 83 ± 7 -5.7
2.3.25.01. Putative platelet activating factor 2hsj Streptococcus pneumoniae 2 0 7.9 ± 0.7 89 ± 4 -8.5
2.3.27.01. Dihydrofolate reductase 3nzb Pneumocystis carinii 1 0 3.9 ± 1.9 72 ± 10 -5.9
2.3.28.01. Aldo-keto reductase family 1 member C21 3fjn Mus musculus 1 0 2.8 ± 1.0 56 ± 3 -5.2
2.3.28.01. Aldo-keto reductase family 1 member C1 1qwk Caenorhabditis elegans 1 0 2.8 ± 1.0 66 ± 3 -6.3
2.4.06.03. S-norcoclaurine synthase 2vq5 Thalictrum flavum (Yellow meadow rue) 4 0 2.6 ± 0.3 90 ± 0 -7.0
2.4.06.04. STAR-related bacterial protein 1t17 Caulobacter crescentus 1 0 3.4 ± 0.7 63 ± 2 -8.1
2.4.06.04. STAR-related bacterial protein 3ggn Deinococcus radiodurans 1 0 5.2 ± 1.6 53 ± 8 -4.1
2.4.11.01. Crambin, enantiomer 3ue7 Designed proteins 1 0 3.4 ± 1.7 89 ± 13 -4.6
2.4.20.01. Cysteine protease 3ois Xylella fastidiosa 1 0 3.2 ± 0.2 80 ± 4 -6.4
2.4.20.03. Protease NSP1 3ifu Porcine reproductive and respiratory syndrome virus 2 0 5.4 ± 1.2 89 ± 15 -9.8
2.4.23.01. Methyl-accepting chemotaxis protein 3eee Thermoanaerobacter tengcongensis 1 0 3.2 ± 0.9 81 ± 4 -5.9
2.4.24.01. Mandelate racemase/muconate lactonizing enzyme 1wue Enterococcus faecalis 2 0 4.0 ± 0.3 86 ± 10 -5.5
2.4.25.01. Uncharacterized N-acetyltransferase SSO0209 2x7b Sulfolobus solfataricus 1 0 3.9 ± 1.5 49 ± 6 -7.6
2.4.26.01. Putative uncharacterized protein 3nrd Rhizobium meliloti 2 0 5.8 ± 0.9 86 ± 3 -13.7
2.4.27.01. Gamma-glutamylaminecyclotransferase 1vkb Mus musculus 1 0 2.3 ± 0.7 72 ± 4 -4.8
2.4.28.01. Phenazine biosynthesis protein PhzF 1s7j Enterococcus faecalis 1 0 1.8 ± 0.7 77 ± 2 -4.3
2.4.29.01. Superantigen-like protein 3r2t Staphylococcus aureus 1 0 4.2 ± 0.0 79 ± 1 -6.2
2.4.35.01. Catalase-related protein 3e4w Mycobacterium paratuberculosis 2 0 9.6 ± 1.3 49 ± 6 -13.4
3.1.03.03. Anticancer peptide designed based on the helix of phosphotransferase IIA 1vm2 Designed proteins 1 0 7.0 ± 1.8 78 ± 15 -12.0
3.1.04.07. Peptide (70-94) of antifreeze protein Afp1 2lq1 Glaciozyma antarctica 1 0 6.2 ± 4.3 87 ± 1 -8.8
3.1.04.07. Peptide (2-25) of antifreeze protein Afp1 2lq0 Glaciozyma antarctica 1 0 4.0 ± 3.8 85 ± 2 -9.5
3.1.04.07. Peptide (119-148) of antifreeze protein Afp1 2lq2 Glaciozyma antarctica 1 0 1.7 ± 2.4 84 ± 6 -8.6
3.1.04.09. Membrane-permeabilizing peptide (654-676) from hemocyanin 2n1c Litopenaeus vannamei (Whiteleg shrimp) 1 0 6.5 ± 1.3 90 ± 9 -6.3
3.1.05.01. Antimicrobial peptide RP-1 2rlg Designed proteins 1 0 5.9 ± 4.2 75 ± 4 -5.0
3.1.05.02. Self-assembling lipopeptide detergent 3cay Designed proteins 2 0 14.5 ± 1.3 78 ± 9 -16.4
3.1.05.03. WYHRLSHLHSRLQD 5mxt Designed proteins 1 0 5.0 ± 0.8 77 ± 10 -6.3
3.1.05.03. Antimicrobial peptide PaDBS1R1 2n9r Designed proteins 1 0 5.6 ± 1.0 83 ± 6 -8.3
3.1.05.03. Glycosaminoglycan-binding (KYE) peptide 2ncw Designed proteins 1 0 5.0 ± 0.4 84 ± 6 -10.1
3.1.05.03. LAK160-P7 2l96 Designed proteins 1 0 1.4 ± 0.9 88 ± 5 -2.7
3.1.05.03. VG16KRKP peptide, structure 2 2n63 Designed proteins 1 0 2.5 ± 0.3 57 ± 4 -4.0
3.1.05.03. Peptide F 1pef Designed proteins 1 0 6.6 ± 1.3 85 ± 10 -7.8
3.1.05.03. LAK160-P12 2l9a Designed proteins 1 0 4.9 ± 3.1 87 ± 1 -6.7
3.1.05.03. Human platelet factor 4 based peptide, 56-70, modified 1djf Designed proteins 1 0 1.9 ± 1.4 87 ± 8 -4.9
3.1.05.03. Lavracin 2n8d Designed proteins 1 0 5.1 ± 1.2 89 ± 13 -5.7
3.1.05.03. LAK160-P10 2l99 Designed proteins 1 0 3.9 ± 2.6 84 ± 0 -5.0
3.1.05.03. GLFDIVKKVVGALG 5mxl Designed proteins 1 0 5.0 ± 0.4 86 ± 6 -7.8
3.1.05.03. VG16KRKP peptide, structure 1 2mxh Designed proteins 1 0 2.5 ± 2.4 82 ± 11 -3.2
3.1.05.04. Distinctin 1xkm Designed proteins 2 0 3.9 ± 0.4 87 ± 2 -4.6
3.1.05.05. Anticoccidial peptide PW2 2jq2 Designed proteins 1 0 6.2 ± 2.3 67 ± 36 -4.5
3.1.05.06. Transportan 1smz Designed proteins 1 0 9.1 ± 0.8 87 ± 7 -8.9
3.1.05.07. Penetratin 1omq Designed proteins 1 0 3.2 ± 1.0 79 ± 7 -7.4
3.1.05.08. MSI-594 derived peptide MSI-594-F5A 2l36 Designed proteins 1 0 6.9 ± 7.0 79 ± 3 -8.3
3.1.05.09. Histidine-rich peptide LAH4 2kjn Designed proteins 1 0 10.5 ± 6.3 89 ± 2 -10.2
3.1.05.10. WALP19 - Pro10 peptide 2lcn Designed proteins 1 1 29.6 ± 6.6 15 ± 7 -12.5
3.1.05.10. WALP19 - Pro8 peptide 2lco Designed proteins 1 0 9.0 ± 0.4 85 ± 4 -15.0
3.1.05.11. ALPS-23 peptide 2m0w Designed proteins 1 0 5.7 ± 0.5 72 ± 6 -9.4
3.1.05.12. Designed transmembrane metallotransporter 4p6j Designed proteins 2 2 22.8 ± 2.0 3 ± 1 -21.9
3.1.05.13. Cullin3-derived peptides 2myl Designed proteins 1 0 3.4 ± 1.2 82 ± 21 -4.4
3.1.06.01. Apolipoprotein E, peptide 281-304 1oef Homo sapiens 1 0 4.8 ± 0.9 88 ± 19 -5.5
3.1.06.01. Apolipoprotein A-I, peptide 190-209 1odq Homo sapiens 1 0 3.3 ± 0.7 87 ± 4 -7.1
3.1.06.02. Amphipathic alpha-helix of apolipoprotein 2irg Designed proteins 1 0 6.4 ± 1.7 83 ± 15 -12.1
3.1.06.02. Class A amphipathic helical peptide 2fq5 Designed proteins 1 0 6.5 ± 1.4 78 ± 6 -8.8
3.1.07.03. Antimicrobial peptide derived from hemagglutinin 2l24 Influenza virus 1 0 8.7 ± 1.3 75 ± 10 -12.6
3.1.11.02. Glucagon-like peptide-1 receptor agonists 2n08 Designed proteins 1 0 6.3 ± 1.3 45 ± 10 -5.4
3.1.21.01. Cecropin (1-7)-melittin (2-9) hybrid 2jmy Designed proteins 1 0 6.5 ± 3.3 77 ± 7 -6.1
3.1.28.05. Aurein 1.2 analogue 2f3a Designed proteins 1 0 3.0 ± 1.6 88 ± 24 -11.7
3.1.28.06. Magainin analogue 2 5cgo Designed proteins 2 0 3.8 ± 0.9 89 ± 2 -10.8
3.1.28.06. Magainin analogue 1 5cgn Designed proteins 2 0 6.1 ± 2.7 88 ± 6 -14.0
3.1.28.06. Magainin analogue, MSI-594 2k98 Designed proteins 1 0 3.2 ± 0.2 86 ± 2 -8.9
3.1.29.01. LL-37-derived peptide 2l5m Designed proteins 1 0 6.1 ± 1.0 89 ± 7 -9.7
3.1.29.01. Retro KR-12 2nal Designed proteins 1 0 3.7 ± 0.5 83 ± 5 -6.1
3.1.29.02. Indolicidin, with P->A substitution 1hr1 Designed proteins 1 0 5.4 ± 4.0 84 ± 9 -8.3
3.2.01.09. Peptidomimetic TWLKKRRWKKAK-D-Pro-P 2m7j Designed proteins 1 0 1.0 ± 1.7 75 ± 37 -2.7
3.2.01.09. Chignolin 5awl Designed proteins 1 0 2.6 ± 2.1 77 ± 28 -2.8
3.2.01.09. Peptide PG-989 2n7n Designed proteins 1 0 6.1 ± 1.4 83 ± 7 -5.5
3.2.01.09. Transthyretin-derived peptide 5hpp Designed proteins 1 0 2.7 ± 1.6 83 ± 6 -5.2
3.2.01.09. Peptide PG-990 2n7o Designed proteins 1 0 7.9 ± 1.6 68 ± 21 -5.6
3.2.05.02. Microcin J25, redesigned, version 1 2mmt Designed proteins 1 0 3.0 ± 0.9 90 ± 5 -5.2
3.2.05.02. Sphingopyxin I 5jqf Sphingopyxis alaskensis 1 0 1.7 ± 1.8 40 ± 16 -3.7
3.2.05.02. Microcin J25, redesigned, version 2 2mmw Designed proteins 1 0 2.6 ± 3.5 90 ± 4 -3.7
3.2.08.01. A macrocyclic beta-sheet peptide 4q8d Designed proteins 2 2 20.8 ± 0.4 10 ± 3 -6.6
3.2.09.01. Octreotide 1soc Designed proteins 1 0 8.9 ± 1.8 77 ± 21 -7.7
3.2.10.01. PawS derived peptide 9 2nb5 Designed proteins 1 0 5.6 ± 1.3 79 ± 14 -6.5
3.2.10.01. PawS derived peptide 4 2lws Designed proteins 1 0 7.5 ± 1.3 37 ± 13 -5.8
3.2.10.01. PawS derived peptide 10 2nb6 Designed proteins 1 0 9.9 ± 2.0 48 ± 30 -9.1
3.2.10.01. PawS derived peptide 11 2lwq Designed proteins 1 0 10.1 ± 1.4 55 ± 22 -9.5
3.2.10.01. PawS derived peptide 6 2lwv Designed proteins 1 0 6.8 ± 1.1 69 ± 16 -7.3
3.2.10.01. PawS derived peptide 7 2lwu Designed proteins 1 0 2.0 ± 1.4 81 ± 10 -3.0
3.2.10.01. PawS derived peptide 5 2lwt Designed proteins 1 0 8.1 ± 2.2 55 ± 21 -5.2
3.2.10.01. PawS derived peptide 22 2ndl Designed proteins 1 0 8.6 ± 2.1 64 ± 9 -5.3
3.2.11.01. Anti-inflammatory peptide 5vav Designed proteins 1 0 7.7 ± 0.8 63 ± 12 -9.0
3.2.11.01. Peptide NC_cEE_D1 5kx2 Designed proteins 1 0 4.9 ± 1.9 70 ± 14 -4.6
3.4.04.03. Tridecaptin A1 2n5y Designed proteins 1 0 2.1 ± 1.0 89 ± 7 -3.9
3.4.07.01. VG16KRKP peptide 2mwl Designed proteins 1 0 4.4 ± 1.3 79 ± 12 -3.6
3.4.07.01. Antimicrobial cationic cyclic hexapeptide 1qvl Designed proteins 1 0 4.2 ± 1.6 84 ± 15 -6.8
3.4.07.02. Compstatin 1a1p Designed proteins 1 0 3.4 ± 1.9 72 ± 18 -5.6